|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash and due from banks | |||||||||||||||||||
| Short-term investments | |||||||||||||||||||
| Total cash and cash equivalents | |||||||||||||||||||
| Equity securities, at fair value | |||||||||||||||||||
| Securities available for sale, at fair value | |||||||||||||||||||
| Securities held to maturity, at amortized cost | |||||||||||||||||||
| Federal Home Loan Bank stock, at cost | |||||||||||||||||||
| Loans held for sale | |||||||||||||||||||
| Loans, net of allowance for loan losses of $19,335 in 2018 and $20,877 in 2017 | |||||||||||||||||||
| Premises and equipment, net | |||||||||||||||||||
| Other real estate owned | |||||||||||||||||||
| Accrued interest receivable | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Core deposit intangible | |||||||||||||||||||
| Net deferred tax asset | |||||||||||||||||||
| Bank-owned life insurance | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Assets | |||||||||||||||||||
| Liabilities | |||||||||||||||||||
| Deposits: | |||||||||||||||||||
| Non-interest bearing | |||||||||||||||||||
| Interest bearing | |||||||||||||||||||
| Total deposits | |||||||||||||||||||
| Short-term borrowings | |||||||||||||||||||
| Long-term debt | |||||||||||||||||||
| Accrued expenses and other liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders' Equity: | |||||||||||||||||||
| Preferred stock, zero par value, (50,000,000 shares authorized; none issued and outstanding) | |||||||||||||||||||
| Total preferred stock, zero par value, (50,000,000 shares authorized; none issued and outstanding) | |||||||||||||||||||
| Common stock, $0.01 par value; 100,000,000 shares authorized, 26,920,613 and 26,827,660 issued and outstanding at December 31, 2018 and 2017, respectively. | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Unearned compensation- ESOP | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Total stockholders' equity | |||||||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||||||
Loading...
